HYDROXYZINE PAMOATE
- Product NDC
- 61919-352
- 11-digit product format
- 619190352
- Labeler code
- 61919
- Product ID
- 61919-352_9c9737dd-859f-1f12-e053-2a95a90ac898
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYDROXYZINE PAMOATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA201507
- Marketing category
- ANDA
- Marketing start
- 2017-02-08
- Marketing end
- 0000-00-00
- Substance
- HYDROXYZINE PAMOATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC],Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-352-30 | HYDROXYZINE PAMOATE | 30 in 1 BOTTLE | CAPSULE | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-352 | HYDROXYZINE PAMOATE CAPSULE [DIRECT RX] | 2 | Legacy NDC, 1 package rows | 20200121_480add5c-5f90-69d8-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-352-30 | 61919035230 | 30 CAPSULE in 1 BOTTLE (61919-352-30) | 30 capsule | 2017-02-08 | 0000-00-00 | No | No | Current |